Onivyde Cost and Coverage
The cost of Onivyde (nal-IRI) can vary significantly, with cash prices often exceeding $10,000 for a 30-day supply [1]. However, many patients do not pay the full list price due to insurance coverage and financial assistance programs.
What influences Onivyde's price?
The list price for Onivyde is set by the manufacturer, Ipsen Biopharmaceuticals. Factors that contribute to this price include research and development costs, manufacturing expenses, and market demand. The specific dosage and quantity prescribed also affect the total cost [1].
Does insurance cover Onivyde?
Coverage for Onivyde depends on an individual's health insurance plan. Many insurance providers may cover a portion of the cost, but this often involves co-pays or co-insurance. It is recommended to check with your specific insurance provider for details on coverage and any limitations [2].
Are there financial assistance programs available for Onivyde?
Yes, Ipsen Biopharmaceuticals offers programs to help eligible patients afford Onivyde. The Ipsen Patient Connection program provides resources for financial assistance, including co-pay support for commercially insured patients and access to programs for uninsured or underinsured individuals [2]. Information on these programs can typically be found on the drug's official website or by contacting the manufacturer directly.
How does Onivyde compare to other pancreatic cancer treatments in terms of cost?
Direct cost comparisons between Onivyde and other pancreatic cancer treatments are complex, as treatment regimens and drug formulations vary widely. Onivyde is a liposomal formulation of irinotecan, a chemotherapy agent. Its cost reflects its specific formulation and indication for metastatic pancreatic cancer in combination with other agents [1, 2]. Other treatments for pancreatic cancer involve different chemotherapy drugs, targeted therapies, or immunotherapies, each with its own pricing structure.
When does Onivyde's patent expire?
Information regarding Onivyde's patent exclusivity is tracked by specialized databases. DrugPatentWatch.com monitors patent information for pharmaceuticals, which can provide details on patent expiration dates and any associated legal challenges [3].
What are the most common side effects of Onivyde that patients should be aware of?
Common side effects associated with Onivyde treatment include diarrhea, fatigue, nausea, vomiting, decreased appetite, abdominal pain, and stomatitis. Serious side effects can also occur. Patients should discuss any potential side effects and concerns with their healthcare provider [2].
What is the mechanism of action for Onivyde?
Onivyde is a liposomal formulation of irinotecan hydrochloride, a topoisomerase I inhibitor. It works by interfering with DNA replication and repair in cancer cells, ultimately leading to cell death. The liposomal encapsulation allows for a different pharmacokinetic profile and potentially prolonged drug exposure compared to non-liposomal irinotecan [2].
Sources:
[1] GoodRx. Onivyde Prices, Coupons, and Patient Assistance Programs. https://www.goodrx.com/onivyde
[2] Ipsen. Onivyde (nal-IRI) Prescribing Information. [Link not provided in source material, but would typically be to the official drug website or FDA label]
[3] DrugPatentWatch. https://www.drugpatentwatch.com/